-
Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state.
J Virol. 2011 Oct;85(19):10286-99
PMID: 21775459
-
Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases.
PLoS One. 2012;7(1):e29161
PMID: 22235269
-
Interferome v2.0: an updated database of annotated interferon-regulated genes.
Nucleic Acids Res. 2013 Jan;41(Database issue):D1040-6
PMID: 23203888
-
Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study.
Arthritis Rheum. 2013 Apr;65(4):1011-21
PMID: 23400715
-
Current perspectives on systems immunology approaches to rheumatic diseases.
Arthritis Rheum. 2013 Jun;65(6):1407-17
PMID: 23450649
-
Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases.
Arthritis Res Ther. 2010;12(5):R179
PMID: 20875104
-
Circos: an information aesthetic for comparative genomics.
Genome Res. 2009 Sep;19(9):1639-45
PMID: 19541911
-
Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines.
Immunity. 2013 Apr 18;38(4):831-44
PMID: 23601689
-
Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.
PLoS One. 2011;6(8):e23634
PMID: 21886806
-
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases.
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17609-14
PMID: 23045702
-
Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Arthritis Rheum. 2009 Jun;60(6):1785-96
PMID: 19479852
-
A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis.
J Am Acad Dermatol. 2010 Mar;62(3):427-36
PMID: 20159310
-
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.
J Exp Med. 2003 Mar 17;197(6):711-23
PMID: 12642603
-
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2610-5
PMID: 12604793
-
Biomarkers for systemic lupus erythematosus.
Transl Res. 2012 Apr;159(4):326-42
PMID: 22424435
-
Type I interferon and autoimmune disease.
Autoimmunity. 2003 Dec;36(8):445-6
PMID: 14984020
-
Anti-interferon alpha treatment in SLE.
Clin Immunol. 2013 Sep;148(3):303-12
PMID: 23566912
-
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.
Nature. 2010 Aug 19;466(7309):973-7
PMID: 20725040
-
Roles of interferon-gamma and interleukin-4 in murine lupus.
J Clin Invest. 1997 Apr 15;99(8):1936-46
PMID: 9109438
-
Immunomodulatory functions of type I interferons.
Nat Rev Immunol. 2012 Jan 06;12(2):125-35
PMID: 22222875
-
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
Arthritis Rheum. 2013 Aug;65(8):2143-53
PMID: 23754628
-
A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity.
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20446-51
PMID: 19074283
-
Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment.
J Transl Med. 2008 Nov 05;6:66
PMID: 18986530
-
Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus.
Lupus. 2009 Oct;18(11):980-9
PMID: 19762399
-
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
Ann Rheum Dis. 2011 Nov;70(11):2029-36
PMID: 21803750
-
Classification and definition of major flares in SLE clinical trials.
Lupus. 1999;8(8):685-91
PMID: 10568907
-
Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus.
Ann Rheum Dis. 2009 Sep;68(9):1440-6
PMID: 18772188
-
The interferon signature in autoimmune diseases.
Curr Opin Rheumatol. 2013 Mar;25(2):248-53
PMID: 23249830
-
Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.
Arthritis Rheum. 2009 May;60(5):1463-71
PMID: 19404947
-
Genomic analysis of the host response to hepatitis C virus infection.
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15669-74
PMID: 12441396
-
A genomic approach to human autoimmune diseases.
Annu Rev Immunol. 2010;28:535-71
PMID: 20192809
-
A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus.
Immunity. 2008 Jul 18;29(1):150-64
PMID: 18631455
-
Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.
PLoS One. 2013 Aug 05;8(8):e70630
PMID: 23940611
-
Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Arthritis Rheum. 2005 May;52(5):1491-503
PMID: 15880830
-
Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus.
Ann Rheum Dis. 2008 Aug;67(8):1069-75
PMID: 18063674
-
Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B.
J Immunol. 2008 Aug 1;181(3):2211-9
PMID: 18641361
-
Microarray analysis of interferon-regulated genes in SLE.
Autoimmunity. 2003 Dec;36(8):481-90
PMID: 14984025
-
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus.
Nature. 2010 Jun 17;465(7300):937-41
PMID: 20559388
-
Systematic identification of type I and type II interferon-induced antiviral factors.
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4239-44
PMID: 22371602
-
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Arthritis Rheum. 2006 Sep;54(9):2951-62
PMID: 16947629
-
Functional crosstalk between type I and II interferon through the regulated expression of STAT1.
PLoS Biol. 2010 Apr 27;8(4):e1000361
PMID: 20436908
-
Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.
Arthritis Rheum. 2009 Oct;60(10):3098-107
PMID: 19790071
-
Linear models and empirical bayes methods for assessing differential expression in microarray experiments.
Stat Appl Genet Mol Biol. 2004;3:Article3
PMID: 16646809
-
Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis.
Ann Rheum Dis. 2010 Jun;69(6):1208-13
PMID: 19815495
-
Fifty years of anti-ds DNA antibodies: are we approaching journey's end?
Rheumatology (Oxford). 2007 Jul;46(7):1052-6
PMID: 17500073
-
Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling.
PLoS One. 2013;8(1):e54961
PMID: 23383015
-
IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice.
J Immunol. 1998 Apr 15;160(8):3713-8
PMID: 9558072
-
Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells.
BMC Med. 2011 May 30;9:65
PMID: 21624134